Clinical trial
Low-dose Glibenclamide in Type 2 Diabetes Mellitus - Part A
NCT02830048 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Low-dose Glibenclamide in Type 2 Diabetes Mellitus - Part A
- Lead sponsor
- University of Oxford
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2016
- Completion date
- March 9, 2017
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.